Treatment
[68Ga]Ga-FAPI-46 clinical trials
We’re tracking 6 recruiting studies that include [68Ga]Ga-FAPI-46, each written for real people, not researchers, below.
Recruiting studies
- NCT05957250Recruiting
PET scan study to better image pancreatic and bile duct cancer
This study uses a special PET scan drug (Ga-FAPI-46) to create clearer pictures of pancreatic and bile duct cancers. It may help doctors decide on the best next steps—especially before surgery—by checking tumor size and looking for spread.
Amsterdam, North HollandAges 18 years+ - NCT06540872RecruitingPhase 2
Testing New PET/MRI Scan in Large DCIS
This study tests a new imaging method that combines a special PET scan (FAPI) with MRI to see if it can better find hidden invasive cancer in people with large areas of ductal carcinoma in situ (DCIS). It aims to improve surgical planning and avoid second surgeries.
Essen, North Rhine-WestphaliaAges 18 years+ - NCT06790082RecruitingPhase 2
FAPI PET scan to diagnose pleural mesothelioma
This trial tests if a newer type of PET scan (FAPI PET) can better diagnose pleural mesothelioma than a standard FDG PET scan. If you have a suspicious spot in your lung lining and need a biopsy, this study may help improve how we find and track this cancer.
Aalborg, Region North JutlandAges 18 years+ - NCT06794372RecruitingPhase 2
68Ga-FAPI-46 PET scan for head and neck cancer staging
This trial tests a new type of PET scan that uses a special tracer (68Ga-FAPI-46) to see if it can better show the extent of head and neck cancers before surgery. It may help doctors plan your treatment more accurately.
Lausanne, Canton of VaudAges 18 years+ - NCT07215182RecruitingPhase 2
New PET scan method for advanced melanoma
This trial tests a new type of PET scan that may find cancer more clearly and quickly than current scans. It's for people with advanced melanoma that has spread and cannot be removed by surgery.
Herlev, Capital RegionAges 18 years+ - NCT07629609RecruitingPhase 2
New PET scan imaging for pancreatic and stomach cancers
This study tests a new type of PET scan (a detailed imaging test) called [68Ga]Ga-FAPI that may help doctors see cancer better and faster than standard scans. You'll receive this experimental scan to see if it improves cancer detection before surgery.
CopenhagenAges 18 years+
What [68Ga]Ga-FAPI-46 is being studied for
Conditions with recruiting [68Ga]Ga-FAPI-46 studies.
Common questions
- Are there clinical trials studying [68Ga]Ga-FAPI-46?
- Yes. Clin2 currently lists 6 recruiting studies that include [68Ga]Ga-FAPI-46, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a [68Ga]Ga-FAPI-46 trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is [68Ga]Ga-FAPI-46 an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether [68Ga]Ga-FAPI-46 or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.